header("Content-type: text/html; charset=iso-8859-1"); ?>
This pocket-size drug treatment card for clinicians provides information on therapy options and recommendations for the co-infected patient including drug interactions and side effects.
The following resources were used in developing this card and should be consulted for more complete and/or up-to-date information:
Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2000; 49 (No. 9)
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council, October 10, 2006
American Academy of Pediatrics, Committee on Infectious Diseases. Tuberculosis. In L.K. Pickering (Ed.), 2006 Red Book: Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006: 678-704.
© 2017, Rutgers, The State University of New Jersey. All rights reserved.
225 Warren Street, Newark, New Jersey 07103